Timothy Henrich, MD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave, #525A
San Francisco CA 94110
Phone628-206-5518
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Yale UniversityM.D.2004School of Medicine
    Harvard UniversityM.M.Sc.2013School of Medicine
    Oberlin CollegeB.A.1996
    Brigham and Women's HospitalInternal Medicine Residency2007
    Massachusetts General Hospital and Brigham and Women's HospitalInfectious Disease Fellowship2009

    Collapse Overview 
    Collapse Overview
    My laboratory/research group specializes in immunmodulatory, cytoreductive chemotherapeutic and stem cell transplantation approaches to HIV-1 cure. We are also involved in the design and implementation of novel nano/microtechnologies and PET-based imaging approaches to characterize viral reservoirs.

    Collapse Research 
    Collapse Research Activities and Funding
    In Vivo PET Imaging of HIV Infection
    NIH R01AI152932Aug 12, 2020 - Jul 31, 2025
    Role: Principal Investigator
    Targeting Non Viral Markers of HIV Persistence
    NIH R01AI141003May 15, 2018 - Apr 30, 2023
    Role: Principal Investigator
    Biomarkers of CNS HIV Persistence
    NIH R21MH116716Mar 1, 2018 - Jan 31, 2021
    Role: Principal Investigator
    Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin
    NIH R33AI116205Sep 1, 2016 - Aug 31, 2021
    Role: Principal Investigator
    Single Cell Characterization of Latent HIV-1 Reservoirs
    NIH R01AI122862Aug 2, 2016 - Jul 31, 2021
    Role: Principal Investigator
    Measurement of Antibody Epitope Signatures by Peptide Microarrays to Determine Recency of HIV Infection
    NIH R21AI122938Jun 24, 2016 - May 31, 2019
    Role: Co-Principal Investigator
    Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin
    NIH R21AI116205Sep 1, 2014 - Aug 31, 2016
    Role: Principal Investigator
    A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs
    NIH R21AI113117Jul 1, 2014 - Jun 30, 2017
    Role: Principal Investigator
    Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells
    NIH R21AI110277Jun 1, 2014 - May 31, 2017
    Role: Principal Investigator
    Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics
    NIH K23AI098480Mar 1, 2012 - Feb 28, 2017
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency. Am J Epidemiol. 2023 Apr 29. Takahashi S, Peluso MJ, Hakim J, Turcios K, Janson O, Routledge I, Busch MP, Hoh R, Tai V, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Greenhouse B, Rodr?guez-Barraquer I. PMID: 37119030.
      View in: PubMed   Mentions:    Fields:    
    2. The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms. medRxiv. 2023 Mar 31. Buck AM, Deitchman AN, Takahashi S, Lu S, Goldberg SA, Hoh R, Williams MC, Kerbleski M, Deveau TM, Munter SE, Lombardo J, Wrin T, Petropoulos CJ, Durstenfeld MS, Hsue PY, Kelly JD, Greenhouse B, Martin JN, Deeks SG, Peluso MJ, Henrich TJ. PMID: 37034660; PMCID: PMC10081395.
      View in: PubMed   Mentions:
    3. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. 2023 03 22; 12. Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB, RECOVER Mechanistic Pathway Task Force. PMID: 36947108; PMCID: PMC10032659.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID. medRxiv. 2023 Mar 21. Durstenfeld MS, Peluso MJ, Kaveti P, Hill C, Li D, Sander E, Swaminathan S, Arechiga VM, Lu S, Goldberg SA, Hoh R, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Kelly JD, Glidden DV, Henrich TJ, Martin JN, Lee YJ, Aras MA, Long CS, Grandis DJ, Deeks SG, Hsue PY. PMID: 35677073; PMCID: PMC9176659.
      View in: PubMed   Mentions:
    5. Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding during Suppressive Antiretroviral Therapy. J Infect Dis. 2023 Mar 07. Hastie E, Moser C, Sun X, Lennox J, Hsue PY, Bosch RJ, Deeks S, Meneses MV, Lederman MM, Hunt P, Henrich TJ, Marconi VC, Gianella S. PMID: 36881933.
      View in: PubMed   Mentions:    Fields:    
    6. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv. 2023 Feb 10. Yin K, Peluso MJ, Thomas R, Shin MG, Neidleman J, Luo X, Hoh R, Anglin K, Huang B, Argueta U, Lopez M, Valdivieso D, Asare K, Ibrahim R, Ständker L, Lu S, Goldberg SA, Lee SA, Lynch KL, Kelly JD, Martin JN, Münch J, Deeks SG, Henrich TJ, Roan NR. PMID: 36798286; PMCID: PMC9934605.
      View in: PubMed   Mentions:
    7. Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients. medRxiv. 2023 Feb 09. Bodansky A, Wang CY, Saxena A, Mitchell A, Takahashi S, Anglin K, Huang B, Hoh R, Lu S, Goldberg SA, Romero J, Tran B, Kirtikar R, Grebe H, So M, Greenhouse B, Durstenfeld MS, Hsue PY, Hellmuth J, Kelly JD, Martin JN, Anderson MS, Deeks SG, Henrich TJ, DeRisi JL, Peluso MJ. PMID: 36798288; PMCID: PMC9934805.
      View in: PubMed   Mentions:
    8. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023 02 01; 133(3). Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, Tai V, Torres L, Iyer NS, Deswal M, Ngo LH, Buitrago M, Rodriguez A, Chen JY, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Deitchman AN, Hellmuth J, Spinelli MA, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Deeks SG, Hunt PW, Henrich TJ. PMID: 36454631; PMCID: PMC9888380.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    9. Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection. bioRxiv. 2023 Jan 12. Dwivedi AK, Siegel DA, Thanh C, Hoh R, Hobbs KS, Pan T, Gibson EA, Martin J, Hecht F, Pilcher C, Milush J, Busch MP, Stone M, Huang ML, Levy CN, Roychoudhury P, Hladik F, Jerome KR, Henrich TJ, Deeks SG, Lee SA. PMID: 36712077; PMCID: PMC9882059.
      View in: PubMed   Mentions:
    10. Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID. J Infect Dis. 2023 01 11; 227(2):246-250. Peluso MJ, Mitchell A, Wang CY, Takahashi S, Hoh R, Tai V, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Wilson MR, Greenhouse B, Deeks SG, DeRisi JL, Henrich TJ. PMID: 36089700; PMCID: PMC9494362.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. PP 4.19 – 00021 Impact of SARS-COV-2-Mediated CD4 T Cell Activation HIV DNA Persistence In Vivo. Journal of Virus Eradication. 2022 Dec 20; 8:100227. Deveau DT, Peluso PM, Buck BA, Kumar KN, Henrich HT. .
      View in: Publisher Site   Mentions:
    12. 442. Clinical Outcomes of Checkpoint Inhibitor Therapy in People with HIV: A Single-Center Case Series. Open Forum Infectious Diseases. 2022 Dec 15; 9(Supplement_2). Sans SH, Jones JB, Isaza IE, Chin-Hong CP, Henrich HT, Peluso PM. .
      View in: Publisher Site   Mentions:
    13. Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size. AIDS. 2023 03 01; 37(3):477-488. Siegel DA, Thanh C, Wan E, Hoh R, Hobbs K, Pan T, Gibson EA, Kroetz DL, Martin J, Hecht F, Pilcher C, Martin M, Carrington M, Pillai S, Busch MP, Stone M, Levy CN, Huang ML, Roychoudhury P, Hladik F, Jerome KR, Kiem HP, Henrich TJ, Deeks SG, Lee SA. PMID: 36695358; PMCID: PMC9894159.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    14. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling. JCI Insight. 2022 09 22; 7(18). Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, Hong KY, Rasmussen H, Miller GE, Bishehsari F, Balk RA, Moy JN, Hoh R, Lu S, Goldman AR, Tang HY, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Kelly JD, Wasse H, Martin JN, Liu Q, Keshavarzian A, Landay A, Deeks SG, Henrich TJ, Abdel-Mohsen M. PMID: 36134654; PMCID: PMC9675436.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    15. Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study. Clin Infect Dis. 2022 Aug 24; 75(1):e916-e919. Spinelli MA, Peluso MJ, Lynch KL, Yun C, Glidden DV, Henrich TJ, Deeks SG, Gandhi M. PMID: 34864962; PMCID: PMC8689738.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    16. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling. JCI Insight. 2022 08 08; 7(15). Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, Hong KY, Rasmussen H, Miller GE, Bishehsari F, Balk RA, Moy JN, Hoh R, Lu S, Goldman AR, Tang HY, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Kelly JD, Wasse H, Martin JN, Liu Q, Keshavarzian A, Landay A, Deeks SG, Henrich TJ, Abdel-Mohsen M. PMID: 35727635; PMCID: PMC9462470.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    17. Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID. medRxiv. 2022 Jul 22. Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, Tai V, Torres L, Iyer NS, Deswal M, Ngo LH, Buitrago M, Rodriguez A, Chen JY, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Deitchman AN, Hellmuth J, Spinelli MA, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Deeks SG, Hunt PW, Henrich TJ. PMID: 35898346; PMCID: PMC9327632.
      View in: PubMed   Mentions:
    18. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection. AIDS. 2022 10 01; 36(12):F7-F16. Peluso MJ, Spinelli MA, Deveau TM, Forman CA, Munter SE, Mathur S, Tang AF, Lu S, Goldberg SA, Arreguin MI, Hoh R, Tai V, Chen JY, Martinez EO, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Sette A, Weiskopf D, Kumar N, Lynch KL, Hunt PW, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Glidden DV, Gandhi M, Deeks SG, Rutishauser RL, Henrich TJ. PMID: 35866847; PMCID: PMC9444925.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    19. Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies. Pathog Immun. 2022; 7(1):95-103. Peluso MJ, Anglin K, Durstenfeld MS, Martin JN, Kelly JD, Hsue PY, Henrich TJ, Deeks SG. PMID: 35800257; PMCID: PMC9254867.
      View in: PubMed   Mentions: 10  
    20. Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol Neuroimmunol Neuroinflamm. 2022 09; 9(5). Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho HE, Lu S, Goldberg SA, Hoh R, Tai V, Munter SE, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Martin JN, Kelly JD, Durstenfeld MS, Hsue PY, Hunt PW, Greene M, Chow FC, Hellmuth J, Henrich TJ, Glidden DV, Deeks SG. PMID: 35701186; PMCID: PMC9210548.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    21. Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms. Clin Infect Dis. 2022 06 10; 74(11):2083-2084. Peluso MJ, Thomas IJ, Munter SE, Deeks SG, Henrich TJ. PMID: 34617982; PMCID: PMC9187313.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    22. Rapid sequential development and rupture of mycotic aneurysms within a period of days in a patient with graft-versus-host disease and angiotropic Scedosporium apiospermum infection. Surg Neurol Int. 2022; 13:242. Budohoski KP, Raygor K, Cook D, Henrich T, Abla AA. PMID: 35855168; PMCID: PMC9282729.
      View in: PubMed   Mentions:
    23. Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection. JCI Insight. 2022 05 23; 7(10). Durstenfeld MS, Peluso MJ, Kelly JD, Win S, Swaminathan S, Li D, Arechiga VM, Zepeda V, Sun K, Shao S, Hill C, Arreguin MI, Lu S, Hoh R, Tai V, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Kornak J, Henrich TJ, Martin JN, Deeks SG, Hsue PY. PMID: 35389890; PMCID: PMC9220849.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    24. Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy. J Clin Invest. 2022 05 16; 132(10). Varco-Merth BD, Brantley W, Marenco A, Duell DD, Fachko DN, Richardson B, Busman-Sahay K, Shao D, Flores W, Engelman K, Fukazawa Y, Wong SW, Skalsky RL, Smedley J, Axthelm MK, Lifson JD, Estes JD, Edlefsen PT, Picker LJ, Cameron CM, Henrich TJ, Okoye AA. PMID: 35316218; PMCID: PMC9106346.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    25. CE-541-04 CARDIAC ARRHYTHMIAS IN POST-ACUTE SEQUELAE OF SARS-COV-2 INFECTION ASSESSED BY AMBULATORY RHYTHM MONITORING. Heart Rhythm. 2022 Apr 28; 19(5):s54-s55. Hill HC, Swaminathan SS, Li LD, Peluso PM, Henrich HT, Martin MJ, Deeks DS, Hsue HP, Durstenfeld DM. .
      View in: Publisher Site   Mentions:
    26. COVID-19 in vaccinated versus unvaccinated hematologic malignancy patients. Transpl Infect Dis. 2022 Apr 15; e13835. DeVoe C, Pandey S, Shariff D, Arora S, Henrich TJ, Yokoe DS, Langelier CR, Servellita V, Chiu C, Miller S, Babik JM, Chin-Hong P, Fung M. PMID: 35426225; PMCID: PMC9115335.
      View in: PubMed   Mentions: 2     Fields:    
    27. SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19. Ann Neurol. 2022 06; 91(6):772-781. Peluso MJ, Deeks SG, Mustapic M, Kapogiannis D, Henrich TJ, Lu S, Goldberg SA, Hoh R, Chen JY, Martinez EO, Kelly JD, Martin JN, Goetzl EJ. PMID: 35285072; PMCID: PMC9082480.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    28. First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody. Nat Commun. 2022 03 09; 13(1):1219. Beckford-Vera DR, Flavell RR, Seo Y, Martinez-Ortiz E, Aslam M, Thanh C, Fehrman E, Pardons M, Kumar S, Deitchman AN, Ravanfar V, Schulte B, Wu IK, Pan T, Reeves JD, Nixon CC, Iyer NS, Torres L, Munter SE, Hyunh T, Petropoulos CJ, Hoh R, Franc BL, Gama L, Koup RA, Mascola JR, Chomont N, Deeks SG, VanBrocklin HF, Henrich TJ. PMID: 35264559; PMCID: PMC8907355.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    29. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Transl Neurol. 2022 02; 9(2):221-226. Apple AC, Oddi A, Peluso MJ, Asken BM, Henrich TJ, Kelly JD, Pleasure SJ, Deeks SG, Allen IE, Martin JN, Ndhlovu LC, Miller BL, Stephens ML, Hellmuth J. PMID: 35043593; PMCID: PMC8862406.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    30. Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement. Open Forum Infect Dis. 2022 Feb; 9(2):ofab640. Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Ngo LH, Deswal M, Munter SE, Martinez EO, Anglin KA, Romero MD, Tavs J, Rugart PR, Chen JY, Sans HM, Murray VW, Ellis PK, Donohue KC, Massachi JA, Weiss JO, Mehdi I, Pineda-Ramirez J, Tang AF, Wenger MA, Assenzio MT, Yuan Y, Krone MR, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Sauceda JA, Gandhi M, Scheffler AW, Hsue PY, Henrich TJ, Deeks SG, Martin JN. PMID: 35106317; PMCID: PMC8755302.
      View in: PubMed   Mentions: 20  
    31. Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery. Int J Behav Med. 2022 Oct; 29(5):610-623. Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA. PMID: 34918211; PMCID: PMC8675303.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    32. LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV. Open Forum Infectious Diseases. 2021 Dec 4; 8(Suppl 1):s805-s805. Spinelli SM, Peluso PM, Lynch LK, Yun YC, Glidden GD, Henrich HT, Deeks DS, Gandhi GM. .
      View in: Publisher Site   Mentions:
    33. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis. 2021 12 01; 224(11):1839-1848. Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, Forman CA, Munter SE, Hoh R, Tai V, Chenna A, Yee BC, Winslow JW, Petropoulos CJ, Greenhouse B, Hunt PW, Hsue PY, Martin JN, Daniel Kelly J, Glidden DV, Deeks SG, Henrich TJ. PMID: 34677601; PMCID: PMC8643408.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    34. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions. Transl Res. 2022 03; 241:1-12. Peluso MJ, Donatelli J, Henrich TJ. PMID: 34780969; PMCID: PMC8588584.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    35. A High Percentage of People With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 11 02; 73(9):e2845-e2846. Peluso MJ, Bakkour S, Busch MP, Deeks SG, Henrich TJ. PMID: 33211091; PMCID: PMC7717237.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    36. TNF-α inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines. AIDS. 2021 11 01; 35(13):2163-2168. Claytor JD, Viramontes O, Conner S, Wen KW, Beck K, Chin-Hong PV, Henrich TJ, Peluso MJ. PMID: 34115645.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency. medRxiv. 2021 Sep 14. Takahashi S, Peluso MJ, Hakim J, Turcios K, Janson O, Routledge I, Busch MP, Hoh R, Tai V, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Greenhouse B, Rodríguez-Barraquer I. PMID: 34545373; PMCID: PMC8452112.
      View in: PubMed   Mentions:
    38. HLA-B*15:01 is associated with asymptomatic SARS-CoV-2 infection. medRxiv. 2021 Sep 10. Augusto DG, Yusufali T, Peyser ND, Butcher X, Marcus GM, Olgin JE, Pletcher MJ, Maiers M, Hollenbach JA. PMID: 34031661; PMCID: PMC8142661.
      View in: PubMed   Mentions:
    39. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518. Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. PMID: 34358460; PMCID: PMC8342976.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    40. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. Sci Adv. 2021 Jul; 7(31). Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Donatelli J, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J, Trinh L, Wrin T, Petropoulos CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. PMID: 34330709; PMCID: PMC8324059.
      View in: PubMed   Mentions: 55     Fields:    
    41. Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease. Open Forum Infect Dis. 2021 Aug; 8(8):ofab393. Peluso MJ, Munter SE, Lynch KL, Yun C, Torres L, Iyer NS, Donatelli J, Ryan L, Deitchman AN, Deeks SG, Rutishauser RL, Henrich TJ. PMID: 34395717; PMCID: PMC8344490.
      View in: PubMed   Mentions: 3  
    42. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients. J Clin Invest. 2021 07 15; 131(14). Stock PG, Henrich TJ, Segev DL, Werbel WA. PMID: 34143755; PMCID: PMC8279579.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsPHPublic Health
    43. Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records. Nat Commun. 2021 06 11; 12(1):3566. Routledge I, Epstein A, Takahashi S, Janson O, Hakim J, Duarte E, Turcios K, Vinden J, Sujishi K, Rangel J, Coh M, Besana L, Ho WK, Oon CY, Ong CM, Yun C, Lynch K, Wu AHB, Wu W, Karlon W, Thornborrow E, Peluso MJ, Henrich TJ, Pak JE, Briggs J, Greenhouse B, Rodriguez-Barraquer I. PMID: 34117227; PMCID: PMC8195995.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    44. multiSero: open multiplex-ELISA platform for analyzing antibody responses to SARS-CoV-2 infection. medRxiv. 2021 May 11. Byrum JR, Waltari E, Janson O, Guo SM, Folkesson J, Chhun BB, Vinden J, Ivanov IE, Forst ML, Li H, Larson AG, Wu W, Tato CM, McCutcheon KM, Peluso MJ, Henrich TJ, Deeks SG, Prakash M, Greenhouse B, Pak JE, Mehta SB. PMID: 34013298; PMCID: PMC8132273.
      View in: PubMed   Mentions:
    45. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV. 2021 06; 8(6):e334-e341. Spinelli MA, Lynch KL, Yun C, Glidden DV, Peluso MJ, Henrich TJ, Gandhi M, Brown LB. PMID: 33933189; PMCID: PMC8084354.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    46. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection. Nat Biotechnol. 2021 08; 39(8):928-935. Elledge SK, Zhou XX, Byrnes JR, Martinko AJ, Lui I, Pance K, Lim SA, Glasgow JE, Glasgow AA, Turcios K, Iyer NS, Torres L, Peluso MJ, Henrich TJ, Wang TT, Tato CM, Leung KK, Greenhouse B, Wells JA. PMID: 33767397; PMCID: PMC8355051.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    47. Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study. medRxiv. 2021 Mar 24. Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA. PMID: 33758881; PMCID: PMC7987040.
      View in: PubMed   Mentions:
    48. Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv. 2021 Mar 12. Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Bautista JA, Ngo LH, Deswal M, Munter SE, Martinez EO, Anglin KA, Romero MD, Tavs J, Rugart PR, Chen JY, Sans HM, Murray VW, Ellis PK, Donohue KC, Massachi JA, Weiss JO, Mehdi I, Pineda-Ramirez J, Tang AF, Wenger M, Assenzio M, Yuan Y, Krone M, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Sauceda JA, Gandhi M, Hsue PY, Henrich TJ, Deeks SG, Martin JN. PMID: 33758895; PMCID: PMC7987054.
      View in: PubMed   Mentions:
    49. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. medRxiv. 2021 Mar 05. Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J, Trinh L, Wrin T, Petroplolous CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. PMID: 33688675; PMCID: PMC7941652.
      View in: PubMed   Mentions: 2  
    50. Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19. medRxiv. 2021 Mar 01. Peluso MJ, Deitchman AN, Torres L, Iyer NS, Nixon CC, Munter SE, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman E, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. PMID: 33688685; PMCID: PMC7941662.
      View in: PubMed   Mentions:
    51. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021 02 13; 10(2). Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, Munter SE, Nixon CC, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Pulliam L. PMID: 33668514; PMCID: PMC7918597.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    52. Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco. Res Sq. 2021 Feb 04. Routledge I, Epstein A, Takahashi S, Janson O, Hakim J, Duarte E, Turcios K, Vinden J, Sujishi K, Rangel J, Coh M, Besana L, Ho WK, Oon CY, Ong CM, Yun C, Lynch K, Wu AHB, Wu W, Karlon W, Thornborrow E, Peluso MJ, Henrich TJ, Pak JE, Briggs J, Greenhouse B, Rodriguez-Barraquer I. PMID: 33564754; PMCID: PMC7872360.
      View in: PubMed   Mentions:
    53. Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo. J Virol. 2021 03 25; 95(8). Gramatica A, Schwarzer R, Brantley W, Varco-Merth B, Sperber HS, Hull PA, Montano M, Migueles SA, Rosenthal D, Hogan LE, Johnson JR, Packard TA, Grimmett ZW, Herzig E, Besnard E, Nekorchuk M, Hsiao F, Deeks SG, Snape M, Kiernan B, Roan NR, Lifson JD, Estes JD, Picker LJ, Verdin E, Krogan NJ, Henrich TJ, Connors M, Ott M, Pillai SK, Okoye AA, Greene WC. PMID: 33536176; PMCID: PMC8103695.
      View in: PubMed   Mentions: 7     Fields:    
    54. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021 02; 27(1):191-195. Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, Greenhouse B, Martin JN, Chow FC, Deeks SG, Greene M, Miller BL, Annan W, Henrich TJ, Peluso MJ. PMID: 33528824; PMCID: PMC7852463.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    55. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. J Leukoc Biol. 2021 07; 110(1):21-26. Corley MJ, Pang APS, Dody K, Mudd PA, Patterson BK, Seethamraju H, Bram Y, Peluso MJ, Torres L, Iyer NS, Premeaux TA, Yeung ST, Chandar V, Borczuk A, Schwartz RE, Henrich TJ, Deeks SG, Sacha JB, Ndhlovu LC. PMID: 33464637; PMCID: PMC8013321.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    56. 969. TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines. Open Forum Infectious Diseases. 2020 Dec 31; 7(Supplement_1):s514-s514. Claytor CJ, Viramontes VO, Conner CS, Wen WK, Beck BK, Henrich HT, Chin-Hong CP, Chin-Hong CP, Peluso PM. .
      View in: Publisher Site   Mentions:
    57. Treatment of immunocompromised COVID-19 patients with convalescent plasma. Transpl Infect Dis. 2021 Apr; 23(2):e13477. Fung M, Nambiar A, Pandey S, Aldrich JM, Teraoka J, Freise C, Roberts J, Chandran S, Hays SR, Bainbridge E, DeVoe C, Roque Gardner A, Yokoe D, Henrich TJ, Babik JM, Chin-Hong P. PMID: 32989856; PMCID: PMC7537112.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    58. Total-Body PET Imaging in Infectious Diseases. PET Clin. 2021 Jan; 16(1):89-97. Henrich TJ, Jones T, Beckford-Vera D, Price PM, VanBrocklin HF. PMID: 33160926.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    59. A “false-positive” HIV test?. . 2020 Nov 1; 37-44. Peluso PM, Henrich HT. .
      View in: Publisher Site   Mentions:
    60. Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community. Open Forum Infectious Diseases. 2020 Oct 30. Appa AA, Takahashi TS, Rodriguez-Barraquer RI, Chamie CG, Sawyer SA, Duarte DE, Hakim HJ, Turcios TK, Vinden VJ, Janson JO, Manglik MA, Peluso PM, Deeks DS, Henrich HT, Torres TL, Rodgers RM, Hackett HJ, Chiu CC, Havlir HD, Greenhouse GB. .
      View in: Publisher Site   Mentions:
    61. Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa531. Appa A, Takahashi S, Rodriguez-Barraquer I, Chamie G, Sawyer A, Duarte E, Hakim J, Turcios K, Vinden J, Janson O, Manglik A, Peluso MJ, Deeks SG, Henrich TJ, Torres L, Rodgers M, Hackett J, Chiu C, Havlir D, Greenhouse B. PMID: 34109255; PMCID: PMC7665736.
      View in: PubMed   Mentions: 8  
    62. Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study. Am J Transplant. 2021 05; 21(5):1765-1779. Henrich TJ, Schreiner C, Cameron C, Hogan LE, Richardson B, Rutishauser RL, Deitchman AN, Chu S, Rogers R, Thanh C, Gibson EA, Zarinsefat A, Bakkour S, Aweeka F, Busch MP, Liegler T, Baker C, Milush J, Deeks SG, Stock PG. PMID: 32780519; PMCID: PMC9177122.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    63. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection. medRxiv. 2020 Aug 21. Elledge SK, Zhou XX, Byrnes JR, Martinko AJ, Lui I, Pance K, Lim SA, Glasgow JE, Glasgow AA, Turcios K, Iyer N, Torres L, Peluso MJ, Henrich TJ, Wang TT, Tato CM, Leung KK, Greenhouse B, Wells JA. PMID: 32839788; PMCID: PMC7444307.
      View in: PubMed   Mentions:
    64. Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community. medRxiv. 2020 Aug 17. Appa A, Takahashi S, Rodriguez-Barraquer I, Chamie G, Sawyer A, Consortium C, Duarte E, Hakim J, Turcios K, Vinden J, Janson O, Manglik A, Peluso MJ, Deeks SG, Henrich TJ, Torres L, Rodgers M, Hackett J, Chiu C, Havlir D, Greenhouse B. PMID: 32839781; PMCID: PMC7444294.
      View in: PubMed   Mentions:
    65. From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation. Curr HIV/AIDS Rep. 2020 08; 17(4):385-393. Prator CA, Donatelli J, Henrich TJ. PMID: 32519184.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    66. Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States. Am J Transplant. 2020 11; 20(11):3225-3233. Fung M, Chiu CY, DeVoe C, Doernberg SB, Schwartz BS, Langelier C, Henrich TJ, Yokoe D, Davis J, Hays SR, Chandran S, Kukreja J, Ng D, Prostko J, Taylor R, Reyes K, Bainbridge E, Bond A, Chin-Hong P, Babik JM. PMID: 32476258; PMCID: PMC7300859.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCellsPHPublic Health
    67. Outcomes of immunomodulatory and biologic therapy in people living with HIV. AIDS. 2020 07 01; 34(8):1171-1179. Peluso MJ, Chen J, Munter S, Reed A, Teraoka J, Eshun-Wilson I, Henrich TJ, Chin-Hong PV. PMID: 32310901; PMCID: PMC9000325.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    68. Biosensing: Tunable Fano-Resonant Metasurfaces on a Disposable Plastic-Template for Multimodal and Multiplex Biosensing (Adv. Mater. 19/2020). Advanced Materials. 2020 May 1; 32(19):2070151. Ahmed AR, Ozen OM, Karaaslan KM, Prator PC, Thanh TC, Kumar KS, Torres TL, Iyer IN, Munter MS, Southern SS, Henrich HT, Inci IF, Demirci DU. .
      View in: Publisher Site   Mentions:
    69. Tunable Fano-Resonant Metasurfaces on a Disposable Plastic-Template for Multimodal and Multiplex Biosensing. Adv Mater. 2020 May; 32(19):e1907160. Ahmed R, Ozen MO, Karaaslan MG, Prator CA, Thanh C, Kumar S, Torres L, Iyer N, Munter S, Southern S, Henrich TJ, Inci F, Demirci U. PMID: 32201997; PMCID: PMC8713081.
      View in: PubMed   Mentions: 10     Fields:    Translation:Cells
    70. Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment Interruption. J Infect Dis. 2020 03 16; 221(7):1146-1155. Prator CA, Thanh C, Kumar S, Pan T, Peluso MJ, Bosch R, Jones N, Milush JM, Bakkour S, Stone M, Busch MP, Deeks SG, Hunt PW, Henrich TJ. PMID: 31677350; PMCID: PMC7325710.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    71. Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. JCI Insight. 2020 02 27; 5(4). Peluso MJ, Bacchetti P, Ritter KD, Beg S, Lai J, Martin JN, Hunt PW, Henrich TJ, Siliciano JD, Siliciano RF, Laird GM, Deeks SG. PMID: 32045386; PMCID: PMC7101154.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    72. Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1. J Virus Erad. 2020 Feb 20; 6(1):19-26. Peluso MJ, Thanh C, Prator CA, Hogan LE, Arechiga VM, Stephenson S, Norris PJ, Di Germanio C, Fuchs D, Zetterberg H, Deeks SG, Gisslén M, Price RW, Henrich TJ. PMID: 32175087; PMCID: PMC7043898.
      View in: PubMed   Mentions: 4  
    73. HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility. J Virol. 2020 01 06; 94(2). Registre L, Moreau Y, Ataca ST, Pulukuri S, Henrich TJ, Lin N, Sagar M. PMID: 31694950; PMCID: PMC6955257.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    74. OP 3.1 Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. Journal of virus eradication. 2019 Dec 1; 5:23. Peluso PM, Bacchetti BP, Ritter RK, Beg BS, Hunt HP, Henrich HT, Siliciano SJ, Siliciano SR, Laird LG, Deeks DS. .
      View in: Publisher Site   Mentions:
    75. OP 4.2 Characterising ‘exceptional’ control among HIV elite controllers. Journal of virus eradication. 2019 Dec 1; 5:31. Peluso PM, Burbelo BP, Kumar KS, Munter MS, Hoh HR, Lee LS, Hunt HP, Rutishauser RR, Henrich HT, Deeks DS. .
      View in: Publisher Site   Mentions:
    76. Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS. AIDS. 2019 12 01; 33 Suppl 2:S107-S111. Winston A, Antinori A, Cinque P, Fox HS, Gisslen M, Henrich TJ, Letendre S, Persaud D, Price RW, Spudich S. PMID: 31790376.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    77. Rapid development of HIV elite control in a patient with acute infection. BMC Infect Dis. 2019 Sep 18; 19(1):815. Morley D, Lambert JS, Hogan LE, De Gascun C, Redmond N, Rutishauser RL, Thanh C, Gibson EA, Hobbs K, Bakkour S, Busch MP, Farrell J, McGetrick P, Henrich TJ. PMID: 31533639; PMCID: PMC6749690.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    78. Seeing Is Believing: Nuclear Imaging of HIV Persistence. Front Immunol. 2019; 10:2077. Henrich TJ, Hsue PY, VanBrocklin H. PMID: 31572355; PMCID: PMC6751256.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    79. CD32-RNA Co-localizes with HIV-RNA in CD3+ Cells Found within Gut Tissues from Viremic and ART-Suppressed Individuals. Pathog Immun. 2019; 4(1):147-160. Vásquez JJ, Aguilar-Rodriguez BL, Rodriguez L, Hogan LE, Somsouk M, McCune JM, Deeks SG, Laszik ZG, Hunt PW, Henrich TJ. PMID: 31139759; PMCID: PMC6508427.
      View in: PubMed   Mentions: 5  
    80. Second example reported of a stem-cell transplant in the clinic leading to HIV remission. Nature. 2019 04; 568(7751):175-176. Henrich TJ. PMID: 30962552.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    81. Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma. Blood Adv. 2018 12 11; 2(23):3479-3482. Wang CC, Thanh C, Gibson EA, Ball-Burack M, Hogan LE, Descours B, Jones N, Carvidi AB, Munter S, Bakkour S, Busch MP, Milush JM, Deeks SG, Henrich TJ. PMID: 30530753; PMCID: PMC6290106.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    82. Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection. Ann Oncol. 2018 10 01; 29(10):2141-2142. Scully EP, Rutishauser RL, Simoneau CR, Delagrèverie H, Euler Z, Thanh C, Li JZ, Hartig H, Bakkour S, Busch M, Alter G, Marty FM, Wang CC, Deeks SG, Lorch J, Henrich TJ. PMID: 30032204; PMCID: PMC6225895.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    83. Progress towards obtaining an HIV cure: slow but sure. Curr Opin HIV AIDS. 2018 09; 13(5):381-382. Henrich TJ, Lelièvre JD. PMID: 29965799.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    84. NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation. Blood Adv. 2018 06 26; 2(12):1412-1416. Hogan LE, Körner C, Hobbs K, Simoneau CR, Thanh C, Gibson EA, Palmer CD, Pandit A, Marty FM, Kuritzkes DR, Jost S, Ritz J, Henrich TJ. PMID: 29921650; PMCID: PMC6020815.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    85. Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation. PLoS One. 2018; 13(5):e0197298. Hogan LE, Hanhauser E, Hobbs KS, Palmer CD, Robles Y, Jost S, LaCasce AS, Abramson J, Hamdan A, Marty FM, Kuritzkes DR, Henrich TJ. PMID: 29746555; PMCID: PMC5944966.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    86. Dolutegravir intensification and HIV persistence: 3 + 1 = 3. Lancet HIV. 2018 05; 5(5):e201-e202. Henrich TJ. PMID: 29643012.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    87. Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. PLoS Pathog. 2018 02; 14(2):e1006856. Hogan LE, Vasquez J, Hobbs KS, Hanhauser E, Aguilar-Rodriguez B, Hussien R, Thanh C, Gibson EA, Carvidi AB, Smith LCB, Khan S, Trapecar M, Sanjabi S, Somsouk M, Stoddart CA, Kuritzkes DR, Deeks SG, Henrich TJ. PMID: 29470552; PMCID: PMC5823470.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    88. Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In Situ. J Histochem Cytochem. 2018 06; 66(6):427-446. Vasquez JJ, Hussien R, Aguilar-Rodriguez B, Junger H, Dobi D, Henrich TJ, Thanh C, Gibson E, Hogan LE, McCune J, Hunt PW, Stoddart CA, Laszik ZG. PMID: 29462571; PMCID: PMC5977441.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    89. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med. 2017 Nov; 14(11):e1002417. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. PMID: 29112956; PMCID: PMC5675377.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansCellsPHPublic Health
    90. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy. J Infect Dis. 2017 07 15; 216(2):254-262. Henrich TJ, Hobbs KS, Hanhauser E, Scully E, Hogan LE, Robles YP, Leadabrand KS, Marty FM, Palmer CD, Jost S, Körner C, Li JZ, Gandhi RT, Hamdan A, Abramson J, LaCasce AS, Kuritzkes DR. PMID: 28838149; PMCID: PMC5853412.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    91. Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV. PLoS Pathog. 2017 Jul; 13(7):e1006488. Hill AL, Rosenbloom DIS, Goldstein E, Hanhauser E, Kuritzkes DR, Siliciano RF, Henrich TJ. PMID: 28683094; PMCID: PMC5500350.
      View in: PubMed   Mentions:    Fields:    
    92. High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay. EBioMedicine. 2017 Jun; 20:217-229. Yucha RW, Hobbs KS, Hanhauser E, Hogan LE, Nieves W, Ozen MO, Inci F, York V, Gibson EA, Thanh C, Shafiee H, El Assal R, Kiselinova M, Robles YP, Bae H, Leadabrand KS, Wang S, Deeks SG, Kuritzkes DR, Demirci U, Henrich TJ. PMID: 28529033; PMCID: PMC5478213.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    93. A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads. Virology. 2017 07; 507:135-139. Charlins P, Schmitt K, Remling-Mulder L, Hogan LE, Hanhauser E, Hobbs KS, Hecht F, Deeks SG, Henrich TJ, Akkina R. PMID: 28432928; PMCID: PMC5901664.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    94. Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies. J Infect Dis. 2017 03 15; 215(suppl_3):S134-S141. Henrich TJ, Deeks SG, Pillai SK. PMID: 28520968; PMCID: PMC5410981.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    95. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016 08; 22(8):839-50. Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, Chomont N, Douek D, Lifson JD, Lo YR, Kuritzkes D, Margolis D, Mellors J, Persaud D, Tucker JD, Barre-Sinoussi F, International AIDS Society Towards a Cure Working Group, Alter G, Auerbach J, Autran B, Barouch DH, Behrens G, Cavazzana M, Chen Z, Cohen ÉA, Corbelli GM, Eholié S, Eyal N, Fidler S, Garcia L, Grossman C, Henderson G, Henrich TJ, Jefferys R, Kiem HP, McCune J, Moodley K, Newman PA, Nijhuis M, Nsubuga MS, Ott M, Palmer S, Richman D, Saez-Cirion A, Sharp M, Siliciano J, Silvestri G, Singh J, Spire B, Taylor J, Tolstrup M, Valente S, van Lunzen J, Walensky R, Wilson I, Zack J. PMID: 27400264; PMCID: PMC5322797.
      View in: PubMed   Mentions: 253     Fields:    Translation:Humans
    96. INTERACTIVE MEDICAL CASE. A Woman with Dyspnea and Altered Mental Status. N Engl J Med. 2016 Jun 09; 374(23):e29. Patel KP, Vaidya A, Gibson CJ, Henrich TJ, Lyons JL. PMID: 27276581.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring. Adv Drug Deliv Rev. 2016 08 01; 103:90-104. Lifson MA, Ozen MO, Inci F, Wang S, Inan H, Baday M, Henrich TJ, Demirci U. PMID: 27262924; PMCID: PMC4943868.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    98. Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV. PLoS Pathog. 2016 04; 12(4):e1005535. Hill AL, Rosenbloom DI, Goldstein E, Hanhauser E, Kuritzkes DR, Siliciano RF, Henrich TJ. PMID: 27119536; PMCID: PMC4847932.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    99. Evolution of coreceptor utilization to escape CCR5 antagonist therapy. Virology. 2016 07; 494:198-214. Zhang J, Gao X, Martin J, Rosa B, Chen Z, Mitreva M, Henrich T, Kuritzkes D, Ratner L. PMID: 27128349; PMCID: PMC4913893.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    100. Ethics of ART interruption after stem-cell transplantation. Lancet HIV. 2016 Jan; 3(1):e8-10. Sugarman J, Lewin SR, Henrich TJ, Rasmussen TA. PMID: 26762996.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    101. Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV. Journal of virus eradication. 2015 Dec 1; 1:13. Hill HA, Rosenbloom RD, Kuritzkes KD, Siliciano SR, Henrich HT. .
      View in: Publisher Site   Mentions:
    102. PP 10.1 Predicting determinants of long-term HIV control with gene therapy strategies. Journal of virus eradication. 2015 Dec 1; 1:41. Hill HA, Hu HL, Hogan HL, Nowak NM, Henrich HT. .
      View in: Publisher Site   Mentions:
    103. CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy. J Infect Dis. 2016 Mar 01; 213(5):766-70. Henrich TJ, Hanhauser E, Harrison LJ, Palmer CD, Romero-Tejeda M, Jost S, Bosch RJ, Kuritzkes DR. PMID: 26512140; PMCID: PMC4747624.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    104. Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1. Open Forum Infect Dis. 2015 Dec; 2(4):ofv123. Rosenbloom DI, Elliott O, Hill AL, Henrich TJ, Siliciano JM, Siliciano RF. PMID: 26478893; PMCID: PMC4602119.
      View in: PubMed   Mentions: 93  
    105. Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics. Proc Natl Acad Sci U S A. 2015 Aug 11; 112(32):E4354-63. Inci F, Filippini C, Baday M, Ozen MO, Calamak S, Durmus NG, Wang S, Hanhauser E, Hobbs KS, Juillard F, Kuang PP, Vetter ML, Carocci M, Yamamoto HS, Takagi Y, Yildiz UH, Akin D, Wesemann DR, Singhal A, Yang PL, Nibert ML, Fichorova RN, Lau DT, Henrich TJ, Kaye KM, Schachter SC, Kuritzkes DR, Steinmetz LM, Gambhir SS, Davis RW, Demirci U. PMID: 26195743; PMCID: PMC4538635.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    106. Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva. Sci Rep. 2015 Jun 05; 5:9919. Shafiee H, Kanakasabapathy MK, Juillard F, Keser M, Sadasivam M, Yuksekkaya M, Hanhauser E, Henrich TJ, Kuritzkes DR, Kaye KM, Demirci U. PMID: 26046668; PMCID: PMC4456945.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    107. HIV eradication: is cord blood the answer? Lancet HIV. 2015 Jun; 2(6):e219-20. Henrich TJ. PMID: 26423188.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    108. Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32. AIDS. 2015 May 15; 29(8):867-76. Henrich TJ, Hanhauser E, Hu Z, Stellbrink HJ, Noah C, Martin JN, Deeks SG, Kuritzkes DR, Pereyra F. PMID: 25730507; PMCID: PMC4473772.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    109. Emerging technologies for point-of-care management of HIV infection. Annu Rev Med. 2015; 66:387-405. Shafiee H, Wang S, Inci F, Toy M, Henrich TJ, Kuritzkes DR, Demirci U. PMID: 25423597.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    110. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann Intern Med. 2014 Sep 02; 161(5):319-27. Henrich TJ, Hanhauser E, Marty FM, Sirignano MN, Keating S, Lee TH, Robles YP, Davis BT, Li JZ, Heisey A, Hill AL, Busch MP, Armand P, Soiffer RJ, Altfeld M, Kuritzkes DR. PMID: 25047577; PMCID: PMC4236912.
      View in: PubMed   Mentions: 247     Fields:    Translation:HumansCells
    111. Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion. AIDS. 2014 Jun 19; 28(10):1539-41. Al-Hajjar SH, Frayha HH, Al-Hazmi M, Batawi R, McIntosh K, Sax PE, Al-Thawadi S, Al-Jumaah S, Busch MP, Hanhauser E, Kuritzkes DR, Li JZ, Henrich TJ. PMID: 24896805; PMCID: PMC4226216.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    112. Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study. Open Forum Infect Dis. 2014 Mar; 1(1):ofu018. Henrich TJ, McLaren PJ, Rao SS, Lin NH, Hanhauser E, Giguel F, Gulick RM, Ribaudo H, de Bakker PI, Kuritzkes DR. PMID: 25734091; PMCID: PMC4324186.
      View in: PubMed   Mentions: 4  
    113. Nanostructured optical photonic crystal biosensor for HIV viral load measurement. Sci Rep. 2014 Feb 28; 4:4116. Shafiee H, Lidstone EA, Jahangir M, Inci F, Hanhauser E, Henrich TJ, Kuritzkes DR, Cunningham BT, Demirci U. PMID: 24576941; PMCID: PMC3937800.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    114. HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat Med. 2014 Feb; 20(2):139-42. Buzon MJ, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, Martin-Gayo E, Leng J, Henrich TJ, Li JZ, Pereyra F, Zurakowski R, Walker BD, Rosenberg ES, Yu XG, Lichterfeld M. PMID: 24412925; PMCID: PMC3959167.
      View in: PubMed   Mentions: 249     Fields:    Translation:HumansCells
    115. Early treatment and HIV-1 reservoirs: a stitch in time? J Infect Dis. 2013 Oct 15; 208(8):1189-93. Henrich TJ, Gandhi RT. PMID: 23852126; PMCID: PMC3778963.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    116. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis. 2013 Jun 01; 207(11):1694-702. Henrich TJ, Hu Z, Li JZ, Sciaranghella G, Busch MP, Keating SM, Gallien S, Lin NH, Giguel FF, Lavoie L, Ho VT, Armand P, Soiffer RJ, Sagar M, Lacasce AS, Kuritzkes DR. PMID: 23460751; PMCID: PMC3636784.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCells
    117. HIV-1 entry inhibitors: recent development and clinical use. Curr Opin Virol. 2013 Feb; 3(1):51-7. Henrich TJ, Kuritzkes DR. PMID: 23290628; PMCID: PMC4213740.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCellsPHPublic Health
    118. Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL. PLoS One. 2012; 7(11):e50065. Henrich TJ, Wood BR, Kuritzkes DR. PMID: 23166820; PMCID: PMC3499490.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    119. Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR. J Virol Methods. 2012 Dec; 186(1-2):68-72. Henrich TJ, Gallien S, Li JZ, Pereyra F, Kuritzkes DR. PMID: 22974526; PMCID: PMC3517891.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    120. HIV-2 encephalitis: case report and literature review. AIDS Patient Care STDS. 2012 Jul; 26(7):383-7. Wood BR, Klein JP, Lyons JL, Milner DA, Phillips RE, Schutten M, Folkerth RD, Ciarlini P, Henrich TJ, Johnson JA. PMID: 22694171.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    121. Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists. Antimicrob Agents Chemother. 2012 Apr; 56(4):1931-5. Henrich TJ, Lewine NR, Lee SH, Rao SS, Berro R, Gulick RM, Moore JP, Tsibris AM, Kuritzkes DR. PMID: 22252820; PMCID: PMC3318367.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    122. SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses. PLoS One. 2011; 6(12):e28047. Tsibris AM, Pal U, Schure AL, Veazey RS, Kunstman KJ, Henrich TJ, Klasse PJ, Wolinsky SM, Kuritzkes DR, Moore JP. PMID: 22164225; PMCID: PMC3229503.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    123. Impact of age, gender, and pregnancy on syphilis screening using the Captia Syphilis-G assay. Sex Transm Dis. 2011 Dec; 38(12):1126-30. Henrich TJ, Yawetz S. PMID: 22082723.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    124. HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug. J Virol. 2012 Jan; 86(2):1119-28. Putcharoen O, Lee SH, Henrich TJ, Hu Z, Vanichanan J, Coakley E, Greaves W, Gulick RM, Kuritzkes DR, Tsibris AM. PMID: 22090117; PMCID: PMC3255837.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    125. Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate. J Acquir Immune Defic Syndr. 2010 Dec; 55(4):420-7. Henrich TJ, Tsibris AM, Lewine NR, Konstantinidis I, Leopold KE, Sagar M, Kuritzkes DR. PMID: 20856130; PMCID: PMC3070184.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    126. Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis. 2010 Nov 15; 202(10):1478-81. Henrich TJ, Li JZ, Felsenstein D, Kotton CN, Plenge RM, Pereyra F, Marty FM, Lin NH, Grazioso P, Crochiere DM, Eggers D, Kuritzkes DR, Tsibris AM. PMID: 20936980; PMCID: PMC2957553.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    127. Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy. Clin Infect Dis. 2010 Jul 01; 51(1):93-8. Henrich TJ, Ribaudo HJ, Kuritzkes DR. PMID: 20504163; PMCID: PMC2880658.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    128. Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: A case report. Am J Dermatopathol. 2010 Apr; 32(2):175-9. Morgan EA, Henrich TJ, Jarell AD, Shieh WJ, Zaki SR, Marty FM, Thorner AR, Milner DA, Velazquez EF. PMID: 19940746.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    129. Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature. Transpl Infect Dis. 2009 Oct; 11(5):458-62. Henrich TJ, Marty FM, Milner DA, Thorner AR. PMID: 19804480.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    130. Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211. Clin Infect Dis. 2009 Mar 01; 48(5):642-9. Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR. PMID: 19191652; PMCID: PMC2756462.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    131. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis. 2009 Mar; 15(3):415-22. Henrich TJ, Krakower D, Bitton A, Yokoe DS. PMID: 19239754; PMCID: PMC2681109.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    132. Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics. J Community Health. 2008 Apr; 33(2):69-77. Henrich TJ, Lauder N, Desai MM, Sofair AN. PMID: 18046634.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    133. Geographic dynamics of viral encephalitis in Thailand. Microbes Infect. 2003 Jun; 5(7):603-11. Henrich TJ, Hutchaleelaha S, Jiwariyavej V, Barbazan P, Nitatpattana N, Yoksan S, Gonzalez JP. PMID: 12787736.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    134. Hantaan virus antibody prevalence in rodent populations of several provinces of northeastern Thailand. Trop Med Int Health. 2002 Oct; 7(10):840-5. Nitatpattana N, Henrich T, Palabodeewat S, Tangkanakul W, Poonsuksombat D, Chauvancy G, Barbazan P, Yoksan S, Gonzalez JP. PMID: 12358618.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    Work in Global Health Equity

    See more options in the Advanced Search tab

    Timothy's Networks
    Concepts (394)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (134)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version pre_new_search-4-g7119b7be on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.